Skip to content
10-Q

Quarterly Report

CytomX Therapeutics, Inc. CTMX

0000950170-25-104991

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 164.91M sh
Shares Diluted Q2 2025 · Jun 30, 2025 129.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 108.93M sh
Shares Diluted Q2 2025 · Jun 30, 2024 84.88M sh
Shares Diluted Q2 2025 · Jun 30, 2024 84.12M sh
Capex Q2 2025 · Jun 30, 2025 $146K
Capex Q2 2025 · Jun 30, 2024 $211K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$36.8M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$45.59M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $49.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $38.05M
Stockholders Equity Q2 2025 · Jun 30, 2025 $119.91M
Stockholders Equity Q2 2025 · Mar 31, 2025 $25.05M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$456K
Stockholders Equity Q2 2025 · Jun 30, 2024 −$31.23M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$31.68M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$47.45M
Current Liabilities Q2 2025 · Jun 30, 2025 $39.22M
Current Liabilities Q2 2025 · Dec 31, 2024 $85.77M
Total Liabilities Q2 2025 · Jun 30, 2025 $55.15M
Total Liabilities Q2 2025 · Dec 31, 2024 $120.99M
Current Assets Q2 2025 · Jun 30, 2025 $164.62M
Current Assets Q2 2025 · Dec 31, 2024 $107.31M
Total Assets Q2 2025 · Jun 30, 2025 $175.06M
Total Assets Q2 2025 · Dec 31, 2024 $120.53M
Sga Expense Q2 2025 · Jun 30, 2025 $6.62M
Sga Expense Q2 2025 · Jun 30, 2025 $16.05M
Sga Expense Q2 2025 · Jun 30, 2024 $8.4M
Sga Expense Q2 2025 · Jun 30, 2024 $16.15M
Rd Expense Q2 2025 · Jun 30, 2025 $13.32M
Rd Expense Q2 2025 · Jun 30, 2025 $32.19M
Rd Expense Q2 2025 · Jun 30, 2024 $25.17M
Rd Expense Q2 2025 · Jun 30, 2024 $47.22M
Net Income Q2 2025 · Jun 30, 2025 −$154K
Net Income Q2 2025 · Jun 30, 2025 $23.37M
Net Income Q2 2025 · Mar 31, 2025 $23.53M
Net Income Q2 2025 · Jun 30, 2024 −$6.53M
Net Income Q2 2025 · Jun 30, 2024 $7.26M
Net Income Q2 2025 · Mar 31, 2024 $13.79M
Operating Income Q2 2025 · Jun 30, 2025 −$1.29M
Operating Income Q2 2025 · Jun 30, 2025 $21.34M
Operating Income Q2 2025 · Jun 30, 2024 −$8.45M
Operating Income Q2 2025 · Jun 30, 2024 $3.21M
Revenue Q2 2025 · Jun 30, 2025 $18.66M
Revenue Q2 2025 · Jun 30, 2025 $69.58M
Revenue Q2 2025 · Jun 30, 2024 $25.12M
Revenue Q2 2025 · Jun 30, 2024 $66.58M